<?xml-stylesheet type='text/xsl' href='anzctrTransform.xsl'?>
<ANZCTR_Trial requestNumber="83167">
  <stage>Registered</stage>
  <submitdate>15/09/2008</submitdate>
  <approvaldate>30/09/2008</approvaldate>
  <actrnumber>ACTRN12608000504314</actrnumber>
  <trial_identification>
    <studytitle>Sleep disruption in quadriplegia  A pilot study exploring whether 3mg melatonin induces sleep</studytitle>
    <scientifictitle>Pilot study examining whether daily administration of 3mg melatonin alters sleep architecture in complete quadriplegia</scientifictitle>
    <utrn />
    <trialacronym />
    <secondaryid>H2010</secondaryid>
  </trial_identification>
  <conditions>
    <healthcondition>Unrefreshing sleep</healthcondition>
    <conditioncode>
      <conditioncode1>Respiratory</conditioncode1>
      <conditioncode2>Other respiratory disorders / diseases</conditioncode2>
    </conditioncode>
  </conditions>
  <interventions>
    <interventions>Two week within subject (pre-post) trial of evening administration of 3mg melatonin delivered orally</interventions>
    <comparator>No control group</comparator>
    <control>Uncontrolled</control>
    <interventioncode>Treatment: drugs</interventioncode>
  </interventions>
  <outcomes>
    <primaryOutcome>
      <outcome>Rapid Eye Movement (REM) sleep latency measured using portable polysomnography</outcome>
      <timepoint>Baseline and two weeks</timepoint>
    </primaryOutcome>
    <secondaryOutcome>
      <outcome>Sleepiness (Karolinska Sleepiness Scale)</outcome>
      <timepoint>Baseline and two weeks</timepoint>
    </secondaryOutcome>
    <secondaryOutcome>
      <outcome>Salivary melatonin concentrations</outcome>
      <timepoint>Baseline and two weeks. Measures made immediately prior to melatonin administration, at participants usual sleep time (2 hours later) and upon awakening the next morning</timepoint>
    </secondaryOutcome>
  </outcomes>
  <eligibility>
    <inclusivecriteria>Complete (motor and sensory) quadriplegia (T1 or higher lesion)</inclusivecriteria>
    <inclusiveminage>18</inclusiveminage>
    <inclusiveminagetype>Years</inclusiveminagetype>
    <inclusivemaxage>80</inclusivemaxage>
    <inclusivemaxagetype>Years</inclusivemaxagetype>
    <inclusivegender>Both males and females</inclusivegender>
    <healthyvolunteer>No</healthyvolunteer>
    <exclusivecriteria>Major psychological or psychiatric disturbances, Neurological damage other than spinal cord injury, Other significant co-morbidity, Beta blockers.</exclusivecriteria>
  </eligibility>
  <trial_design>
    <studytype>Interventional</studytype>
    <purpose>Treatment</purpose>
    <allocation>Non-randomised trial</allocation>
    <concealment />
    <sequence />
    <masking />
    <assignment />
    <designfeatures />
    <endpoint />
    <statisticalmethods />
    <masking1 />
    <masking2 />
    <masking3 />
    <masking4 />
    <patientregistry />
    <followup />
    <followuptype />
    <purposeobs />
    <duration />
    <selection />
    <timing />
  </trial_design>
  <recruitment>
    <phase>Phase 4</phase>
    <anticipatedstartdate>1/09/2008</anticipatedstartdate>
    <actualstartdate>1/09/2008</actualstartdate>
    <anticipatedenddate />
    <actualenddate>1/03/2009</actualenddate>
    <samplesize>5</samplesize>
    <actualsamplesize>5</actualsamplesize>
    <recruitmentstatus>Completed</recruitmentstatus>
    <recruitmentcountry>Australia</recruitmentcountry>
    <recruitmentstate />
  </recruitment>
  <sponsorship>
    <primarysponsortype>Hospital</primarysponsortype>
    <primarysponsorname>Austin Health</primarysponsorname>
    <primarysponsoraddress>Studley Rd, Heidelberg 3084 Vic</primarysponsoraddress>
    <primarysponsorcountry>Australia</primarysponsorcountry>
    <fundingsource>
      <fundingtype>Other Collaborative groups</fundingtype>
      <fundingname>Institute for breathing and sleep</fundingname>
      <fundingaddress>Studley Rd, Heidelberg 3084 Vic</fundingaddress>
      <fundingcountry>Australia</fundingcountry>
    </fundingsource>
    <secondarysponsor>
      <sponsortype>None</sponsortype>
      <sponsorname />
      <sponsoraddress />
      <sponsorcountry />
    </secondarysponsor>
  </sponsorship>
  <ethicsAndSummary>
    <summary>This study will collect preliminary, pilot data regarding the feasibility and utility of supplemental melatonin to treat delayed sleep in quadriplegia</summary>
    <trialwebsite />
    <publication>Spong J, Kennedy GA, Brown DJ, Armstrong SM &amp; Berlowitz D. Melatonin supplementation in patients with complete tetraplegia and poor sleep. Sleep Disorders. 2013. Vol 2013 (Article ID 128197) 8 pages.doi:1155/2013/128197</publication>
    <ethicsreview>Approved</ethicsreview>
    <publicnotes />
    <ethicscommitee>
      <ethicname>Austin Hospital Human Research Ethics Unit</ethicname>
      <ethicaddress>Research Ethics Unit
Level 8 HSB - Room 8322
Austin hospital.
PO Box 5555 Heidelberg Vic 3084</ethicaddress>
      <ethicapprovaldate>3/09/2008</ethicapprovaldate>
      <hrec>H2008/03303</hrec>
      <ethicsubmitdate />
      <ethiccountry>Australia</ethiccountry>
    </ethicscommitee>
  </ethicsAndSummary>
  <attachment />
  <contacts>
    <contact>
      <title>A/Prof</title>
      <name>David Berlowitz</name>
      <address>Institute for Breathing and Sleep
Bowen Centre. Austin Health
Studley Rd. Heidelberg Vic 3084</address>
      <phone>0394963688</phone>
      <fax />
      <email>david.berlowitz@austin.org.au</email>
      <country>Australia</country>
      <type>Scientific Queries</type>
    </contact>
    <contact>
      <title>A/Prof</title>
      <name>David Berlowitz</name>
      <address>Institute for Breathing and Sleep
Bowen Centre. Austin Health
Studley Rd. Heidelberg Vic 3084</address>
      <phone>0394963688</phone>
      <fax />
      <email>david.berlowitz@austin.org.au</email>
      <country>Australia</country>
      <type>Public Queries</type>
    </contact>
    <contact>
      <title />
      <name />
      <address />
      <phone />
      <fax />
      <email />
      <country />
      <type>Updating Information</type>
    </contact>
    <contact>
      <title>A/Prof</title>
      <name>David Berlowitz</name>
      <address>Bowen Centre
Austin Health. Studley Rd Heidelberg 3084</address>
      <phone>061394963871</phone>
      <fax />
      <email>david.berlowitz@austin.org.au</email>
      <country>Australia</country>
      <type>Principal Investigator</type>
    </contact>
  </contacts>
</ANZCTR_Trial>